title: [Are COX-2 inhibitors indicated for patients at risk?].
authors.affiliation: DAP Granollers. Institut Català de la Salut (ICS). Barcelona. Spain. moms@granollers.scs.es
authors.forename: M
authors.initials: M
authors.lastname: Oms Arias
authors.forename: R M
authors.initials: RM
authors.lastname: Morral Parente
mesh_terms: D051546:Cyclooxygenase 2; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use*; D019317:Evidence-Based Medicine; D006801:Humans; D007527:Isoenzymes / Q000037:antagonists & inhibitors*; D008565:Membrane Proteins; D011451:Prostaglandin-Endoperoxide Synthases; D012307:Risk Factors
chemical_list: D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors; D007527:Isoenzymes; D008565:Membrane Proteins; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D011451:Prostaglandin-Endoperoxide Synthases